Pharma Accused of Creating Less Effective Aspirin Tablets To Justify
Expensive Blood Thinners
by Bill Sardi: If
Debt Limit Is Abolished, What Will Happen to the Price of Gold?
A report in
the New York Times accuses Big Pharma of rigging the ineffectiveness
of cheaper blood thinners like aspirin to covertly coerce doctors
into prescribing more expensive pills like Plavix and Warfarin (coumadin).
York Times report emanates from a study published in Circulation,
a journal of The American Heart Association, which found the problem
of aspirin resistance, estimated to affect 5-40% of aspirin users,
is not physiological resistance at all but rather ineffectiveness
caused by the enteric coating of the aspirin pills.
who made this discovery covered for the drug company by calling
the problem "An Unintended Consequence of Enteric Coating Aspirin."
But the New York Times article said "some prominent
doctors say that the prevalence of the condition has been exaggerated
by companies and drug makers with a commercial interest in proving
that aspirin – a relatively iinexpensive, over-the-counter drug
whose heart benefits have been known since the 1950s – does not
In the first
phase of the study researchers gave plain aspirin to 40 subjects
and found no aspirin resistance. Then in a second phase of the study
360 subjects received coated aspirin tablets, said to be "safer"
because the coating protects against bleeding gastric ulcers which
can have mortal consequences for elderly patients, and 108 of them
were resistant up to 8 hours after taking aspirin. A third phase
of the study found no cases of aspirin resistance among 400 subjects.
dismissed the findings of the report saying eventually the aspirin
worked to prevent blood clots over time. But patients at risk for
a heart attack weren't protected from clots that can form in coronary
arteries in the first hours after taking aspirin.
A check on
the history of this problem reveals enteric coating as a possible
cause of aspirin resistance was first
posed in the medical literature in 2008. Two years earlier researchers
coating appeared to reduce the effectiveness of aspirin, but
didn't relate this to aspirin resistance.
A cursory investigation
shows that two widely touted prescription blood thinners, Plavix
and Warfarin (coumadin), sell for around 96-cents and 59-cents per
tablet while enteric-coated aspirin tablets run around 4-cents apiece.
Â© 2012 Bill Sardi, Knowledge of Health, Inc. Not for
posting on other websites.
him mail] is a frequent writer on health and political
topics. His health writings can be found at www.naturalhealthlibrarian.com.
latest book is Downsizing
© 2012 Bill Sardi Word of Knowledge Agency, San Dimas, California.
This article has been written exclusively for www.LewRockwell.com
and other parties who wish to refer to it should link rather than
post at other URLs.
Best of Bill Sardi